Literature DB >> 16790903

Nuclear medicine dosimetry.

Michael Stabin1.   

Abstract

A brief overview is provided of the history of the development of internal dose methods for use in nuclear medicine. Basic methods of internal dosimetry and the systems that have been developed for use in nuclear medicine are described. The development of the MIRD system and the International Radiopharmaceutical Dosimetry Symposium series is outlined. The evolution of models and tools for calculating dose estimates is reviewed. Current efforts in developing more patient-specific methods, particularly for use in therapy calculations, development of small scale and microdosimetry techniques, and of relating internal radiation doses to observed biological effects are described and evaluated.

Entities:  

Mesh:

Year:  2006        PMID: 16790903     DOI: 10.1088/0031-9155/51/13/R12

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  13 in total

Review 1.  Task-based measures of image quality and their relation to radiation dose and patient risk.

Authors:  Harrison H Barrett; Kyle J Myers; Christoph Hoeschen; Matthew A Kupinski; Mark P Little
Journal:  Phys Med Biol       Date:  2015-01-07       Impact factor: 3.609

2.  131I-tositumomab radioimmunotherapy: initial tumor dose-response results using 3-dimensional dosimetry including radiobiologic modeling.

Authors:  Yuni K Dewaraja; Matthew J Schipper; Peter L Roberson; Scott J Wilderman; Hanan Amro; Denise D Regan; Kenneth F Koral; Mark S Kaminski; Anca M Avram
Journal:  J Nucl Med       Date:  2010-06-16       Impact factor: 10.057

3.  Use of integrated SPECT/CT imaging for tumor dosimetry in I-131 radioimmunotherapy: a pilot patient study.

Authors:  Yuni K Dewaraja; Scott J Wilderman; Kenneth F Koral; Mark S Kaminski; Anca M Avram
Journal:  Cancer Biother Radiopharm       Date:  2009-08       Impact factor: 3.099

4.  A review of 3D image-based dosimetry, technical considerations and emerging perspectives in 90Y microsphere therapy.

Authors:  Jim O' Doherty
Journal:  J Diagn Imaging Ther       Date:  2015-04-28

5.  Treatment of carcinoma in situ of the urinary bladder with an alpha-emitter immunoconjugate targeting the epidermal growth factor receptor: a pilot study.

Authors:  Michael E Autenrieth; Christof Seidl; Frank Bruchertseifer; Thomas Horn; Florian Kurtz; Benedikt Feuerecker; Calogero D'Alessandria; Christian Pfob; Stephan Nekolla; Christos Apostolidis; Saed Mirzadeh; Jürgen E Gschwend; Markus Schwaiger; Klemens Scheidhauer; Alfred Morgenstern
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-11       Impact factor: 9.236

6.  Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry.

Authors:  Andrew R Prideaux; Hong Song; Robert F Hobbs; Bin He; Eric C Frey; Paul W Ladenson; Richard L Wahl; George Sgouros
Journal:  J Nucl Med       Date:  2007-05-15       Impact factor: 10.057

7.  A comparison of thyroidal protection by iodine and perchlorate against radioiodine exposure in Caucasians and Japanese.

Authors:  A Rump; S Eder; C Hermann; A Lamkowski; M Kinoshita; T Yamamoto; M Abend; N Shinomiya; M Port
Journal:  Arch Toxicol       Date:  2021-05-18       Impact factor: 5.153

Review 8.  Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review.

Authors:  Daphne Merel Valerie Huizing; Berlinda Jantina de Wit-van der Veen; Marcel Verheij; Marcellus Petrus Maria Stokkel
Journal:  EJNMMI Res       Date:  2018-08-29       Impact factor: 3.138

Review 9.  The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI.

Authors:  Monique R Bernsen; Pieter E B Vaissier; Roel Van Holen; Jan Booij; Freek J Beekman; Marion de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05       Impact factor: 9.236

10.  A comparison of thyroidal protection by stable iodine or perchlorate in the case of acute or prolonged radioiodine exposure.

Authors:  Stefan Eder; Cornelius Hermann; Andreas Lamkowski; Manabu Kinoshita; Tetsuo Yamamoto; Michael Abend; Nariyoshi Shinomiya; Matthias Port; Alexis Rump
Journal:  Arch Toxicol       Date:  2020-07-12       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.